Minimising antibiotic resistance

Lancet Infectious Diseases

Volumn 5, Issue 11, 2005, Pages 668-670

  Sang, Hee Lee ^a   Seok, Hoon Jeong ^b   Cha, Sun Shin ^c  

^a Myong Ji University   (South Korea)

^b Kosin University   (South Korea)

^c Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; OMEPRAZOLE; TRICLOSAN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIAL VIRULENCE; CLINICAL TRIAL; DRUG EFFICACY; FEBRILE NEUTROPENIA; HEALTH CARE; HEALTH CARE PERSONNEL; HELICOBACTER INFECTION; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RISK; META ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SYSTEMATIC REVIEW; VIRUS INFECTION;

EID: 27144508075     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(05)70247-4     Document Type: Letter

References (19)

1. DM Livermore Minimising antibiotic resistance Lancet Infect Dis 5 2005 450 459
2. FJ Angulo, VN Nargund, TC Chiller Evidence of an association between use of anti-microbial agents in food animals and anti-microbial resistance among bacteria isolated from humans and the human health consequences of such resistance J Vet Med B Infect Dis Vet Public Health 51 2004 374 379
3. R Chuanchuen, K Beinlich, TT Hoang, A Becher, RR Karkhoff-Schweizer, HP Schweizer Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ Antimicrob Agents Chemother 45 2001 428 432
4. R Chuanchuen, CT Narasaki, HP Schweizer The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan J Bactriol 184 2002 5036 5044
5. BD Cookson, H Farrelly, P Stapleton, RP Garvey, MR Price Transferable resistance to triclosan in MRSA Lancet 337 1991 1548 1549
6. A Sullivan, B Wretlind, CE Nord Will triclosan in toothpaste select for resistant oral streptococci? Clin Microbiol Infect 9 2003 306 309
7. C Walker, LC Borden, JJ Zambon, CY Bonta, W DeVizio, AR Volpe The effects of a 0.3% triclosan-containg dentifrice on the microbial composition of supragingival plaque J Clin Periodontol 21 1994 334 341
8. RG Finch, JP Metlay, PG Davey, LJ Baker Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002 Lancet Infect Dis 4 2004 44 53
9. N Safdar, J Handelsman, DG Maki Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? Lancet Infect Dis 4 2004 519 527
10. M Paul, L Leibovici Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia Lancet Infect Dis 5 2005 192 193
11. P Furno, G Bucaneve, AD Favero Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis Lancet Infect Dis 2 2002 231 242
12. JH Lee, JH Shin, IH Roe Impact of clarithromycin resistance on eradication of Helicobacter pylori in infected adults Antimicrob Agents Chemother 49 2005 1600 1603
13. PA Bradford Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat Clin Microbiol Rev 14 2001 933 951
14. M Nukaga, S Haruta, K Tanimoto Molecular evolution of a class C β-lactamase extending its substrate specificity J Biol Chem 270 1995 5729 5735
15. M Nukaga, S Kumar, K Nukaga, RF Pratt, JR Knox Hydrolysis of third-generation cephalosporins by class C β-lactamases: structures of a transition state analog of cefotaxime in wild-type and extended spectrum enzymes J Biol Chem 279 2004 9344 9352
16. G Barnaud, R Labia, L Raskine, MJ Sanson-Le Pors, A Philippon, G Arlet Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate FEMS Microbiol Lett 195 2001 185 190
17. SJ Lee, JY Kim, HI Jung Crystallization and preliminary X-ray crystallographic analyses of CMY-1 and CMY-10, plasmidic class C β-lactamases with extended substrate spectrum Acta Crystallogr D Biol Crystallogr 60 2004 328 424
18. L Poirel, Gniadkowski, P Nordman Biochemical analysis of ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3 J Antimicrob Agents 50 2002 1031 1034
19. JH Lee, HI Jung, JH Jung Dissemination of transferable AmpC-type β-lactamase (CMY-10) in a Korean hospital Microb Drug Resist 10 2004 224 230